Hepatic Tumors: Contrast Agent-Enhancement Patterns with Pulse-Inversion Harmonic US
Top Cited Papers
- 1 August 2000
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 216 (2), 411-417
- https://doi.org/10.1148/radiology.216.2.r00jl21411
Abstract
To evaluate contrast agent-enhancement patterns in hepatic hemangiomas, hepatic metastases, and hepatocellular carcinomas (HCCs) at pulse-inversion harmonic ultrasonography (US) with a microbubble contrast agent. Twenty hepatic hemangiomas in 20 patients and 41 malignant hepatic tumors in 23 patients (33 metastases and eight HCCs) were evaluated with pulse-inversion harmonic US. US images were obtained before injection and every 10-15 seconds after injection of a 4-g bolus (300 mg/mL) of SH U 508A (a microbubble contrast agent) for 5 minutes. The contrast-enhancement patterns of 61 hepatic lesions were assessed. Of 20 hemangiomas, 19 revealed peripheral enhancement, which was globular in 14 (70%) and rimlike in five (25%), with centripetal fill-in; the remaining one (5%) showed homogeneous enhancement. In 33 metastases, the enhancement was rimlike in 16 (48%), homogeneous in seven (21%), and stippled in two (6%); in the remaining eight metastases (24%), no enhancement was seen. Of eight HCCs, four (50%) showed homogeneous enhancement and the remaining four (50%) showed heterogeneous enhancement. Centripetal fill-in of lesions with intratumoral enhancement was not seen in any malignancy. Pulse-inversion harmonic US with a microbubble contrast agent is potentially useful for the specific diagnosis of hemangiomas that demonstrate characteristic enhancement features.Keywords
This publication has 17 references indexed in Scilit:
- Limitations of characterization of hepatic hemangiomas using a sonographic contrast agent (Levovist) and power Doppler ultrasonography.Journal of Ultrasound in Medicine, 1999
- Doppler sonographic enhancement of hepatic hemangiomas and hepatocellular carcinomas after perflenapent emulsion: preliminary study.Journal of Ultrasound in Medicine, 1999
- Hepatocellular carcinoma: power Doppler US with a contrast agent--preliminary results.Radiology, 1998
- Value of contrast-enhanced color Doppler sonography in diagnosing hepatocellular carcinoma with special attention to the “color-filled pattern”Journal of Clinical Ultrasound, 1998
- Cavernous hemangioma of the liver: pathologic correlation with dynamic CT findings.Radiology, 1997
- Possibility of differentiating small hyperechoic liver tumours using contrast-enhanced colour doppler ultrasonography: A preliminary studyClinical Radiology, 1997
- Color Doppler ultrasound of liver lesions: Signal enhancement after intravenous injection of the ultrasound contrast agent Levovist®Journal of Clinical Ultrasound, 1996
- Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings.American Journal of Roentgenology, 1994
- Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images.Radiology, 1994
- Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T.Radiology, 1993